Carl Byrnes
Stock Analyst at Northland Capital Markets
(2.55)
# 2,194
Out of 5,149 analysts
26
Total ratings
52.63%
Success rate
15.3%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BWAY BrainsWay | Maintains: Outperform | $19 → $23 | $23.18 | -0.78% | 5 | Nov 12, 2025 | |
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $23.63 | +132.75% | 1 | Sep 3, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $20.17 | +53.69% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.94 | +153.04% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $1.40 | +328.57% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.69 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $14.35 | +74.22% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $4.74 | +4,963.29% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $34.67 | +130.75% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $4.76 | +383.19% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $2.91 | +724.74% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.64 | +75,657.58% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.15 | - | 1 | Sep 27, 2017 |
BrainsWay
Nov 12, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $23.18
Upside: -0.78%
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $23.63
Upside: +132.75%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $20.17
Upside: +53.69%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.94
Upside: +153.04%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $1.40
Upside: +328.57%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.69
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $14.35
Upside: +74.22%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $4.74
Upside: +4,963.29%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $34.67
Upside: +130.75%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $4.76
Upside: +383.19%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $2.91
Upside: +724.74%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.64
Upside: +75,657.58%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.15
Upside: -